Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Health Sciences Psychology

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Search Professor Dan Siskind’s works on UQ eSpace

376 works between 2007 and 2025
All (376) Journal Article (286) Book Chapter (1) Conference Publication (83) Other Outputs (6)

221 - 240 of 376 works

2019

Conference Publication

What To Do When Clozapine Response Is Inadequate? Augmentation Strategies

Siskind, D., Lee, M., Ravindran, A., Zhang, Q., Ma, E., Motamarri, B. and Kisely, S. (2019). What To Do When Clozapine Response Is Inadequate? Augmentation Strategies. RANZCP 2019 Congress, Cairns, QLD Australia, 12–16 May 2019. London, United Kingdom: Sage Publications.

What To Do When Clozapine Response Is Inadequate? Augmentation Strategies

2019

Conference Publication

What Have We Learnt From More Than 20 Years of Clinically Operated Community-Based Residential Rehabilitation For Severe Mental Illness in Australia

Parker, S., Hopkins, G., Siskind, D., Harris, M., McKeon, G. and Dark, F. (2019). What Have We Learnt From More Than 20 Years of Clinically Operated Community-Based Residential Rehabilitation For Severe Mental Illness in Australia. RANZCP Congress, Cairns, QLD Australia, 12-16 May 2019. London, United Kingdom: Sage Publications.

What Have We Learnt From More Than 20 Years of Clinically Operated Community-Based Residential Rehabilitation For Severe Mental Illness in Australia

2018

Journal Article

Do reductions in ghrelin contribute towards antipsychotic-induced weight gain?

Firth, Joseph, Teasdale, Scott B., Jackson, Sarah E., Vancampfort, Davy, Siskind, Dan, Sarris, Jerome and Solmi, Marco (2018). Do reductions in ghrelin contribute towards antipsychotic-induced weight gain?. Schizophrenia Research, 18, 30739-30740. doi: 10.1016/j.schres.2018.12.043

Do reductions in ghrelin contribute towards antipsychotic-induced weight gain?

2018

Journal Article

Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study

Tuesley, Karen M., Jordan, Susan J., Siskind, Dan J., Kendall, Bradley J. and Kisely, Steve (2018). Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study. Australian & New Zealand Journal of Psychiatry, 53 (6), 550-558. doi: 10.1177/0004867418814945

Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study

2018

Journal Article

Weight gain correlated with decrease in clozapine/N-desmethyl-clozapine ratio in a man with treatment-refractory schizophrenia

De Mel, Vidanelage Nimmi, Korman, Nicole, McArdle, Peter and Siskind, Dan J. (2018). Weight gain correlated with decrease in clozapine/N-desmethyl-clozapine ratio in a man with treatment-refractory schizophrenia. Australasian Psychiatry, 26 (5), 558-559. doi: 10.1177/1039856218772253

Weight gain correlated with decrease in clozapine/N-desmethyl-clozapine ratio in a man with treatment-refractory schizophrenia

2018

Journal Article

Glucagon-like peptide-1 receptor-agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis

Siskind, Dan, Hahn, Margaret, Correll, Christoph U, Fink-Jensen, Anders, Russell, Anthony W, Bak, Nikolaj, Broberg, Brian V, Larsen, Julie, Ishøy, Pelle L, Vilsbøll, Tina, Knop, Filip K, Kisely, Steve and Ebdrup, Bjørn H (2018). Glucagon-like peptide-1 receptor-agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis. Diabetes, Obesity and Metabolism, 21 (2), 293-302. doi: 10.1111/dom.13522

Glucagon-like peptide-1 receptor-agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis

2018

Journal Article

Protocol for a randomised controlled trial of interventions to promote adoption and maintenance of physical activity in adults with mental illness

Chapman, Justin J., Suetani, Shuichi, Siskind, Dan, Kisely, Steve, Breakspear, Michael, Byrne, Jacqueline H. and Patterson, Sue (2018). Protocol for a randomised controlled trial of interventions to promote adoption and maintenance of physical activity in adults with mental illness. BMJ Open, 8 (9) e023460, e023460. doi: 10.1136/bmjopen-2018-023460

Protocol for a randomised controlled trial of interventions to promote adoption and maintenance of physical activity in adults with mental illness

2018

Journal Article

Delusions in Parkinson’s disease: a systematic review of published cases

Warren, Nicola, O’Gorman, Cullen, Hume, Zena, Kisely, Steve and Siskind, Dan (2018). Delusions in Parkinson’s disease: a systematic review of published cases. Neuropsychology Review, 28 (3), 310-316. doi: 10.1007/s11065-018-9379-3

Delusions in Parkinson’s disease: a systematic review of published cases

2018

Journal Article

Evaluating the feasibility of a pilot exercise intervention implemented within a residential rehabilitation unit for people with severe mental illness: GO HEART: (group occupational health exercise and rehabilitation treatment)

Korman, Nicole H., Shah, Shelukumar, Suetani, Shuichi, Kendall, Karen, Rosenbaum, Simon, Dark, Frances, Nadareishvili, Ketevan and Siskind, Dan (2018). Evaluating the feasibility of a pilot exercise intervention implemented within a residential rehabilitation unit for people with severe mental illness: GO HEART: (group occupational health exercise and rehabilitation treatment). Frontiers in Psychiatry, 9 (JUL) 343, 1-11. doi: 10.3389/fpsyt.2018.00343

Evaluating the feasibility of a pilot exercise intervention implemented within a residential rehabilitation unit for people with severe mental illness: GO HEART: (group occupational health exercise and rehabilitation treatment)

2018

Journal Article

Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis

Warren, N., Siskind, D. and O'Gorman, C. (2018). Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis. Acta Psychiatrica Scandinavica, 138 (5), 401-408. doi: 10.1111/acps.12941

Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis

2018

Journal Article

Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: a systematic review and meta-analysis

Oakley, Padraig, Kisely, Steve, Baxter, Amanda, Harris, Meredith, Desoe, Jocelyne, Dziouba, Alyona and Siskind, Dan (2018). Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: a systematic review and meta-analysis. Journal of Psychiatric Research, 102, 245-253. doi: 10.1016/j.jpsychires.2018.04.019

Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: a systematic review and meta-analysis

2018

Journal Article

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018)

Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018). Psychopharmacology, 235 (7), 2193-2193. doi: 10.1007/s00213-018-4909-5

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018)

2018

Journal Article

Real-world effectiveness of clozapine for intellectual disability: results from a mirror-image and a reverse-mirror-image study

Rohde, Christopher, Hilker, Rikke, Siskind, Dan and Nielsen, Jimmi (2018). Real-world effectiveness of clozapine for intellectual disability: results from a mirror-image and a reverse-mirror-image study. Journal of Psychopharmacology, 32 (11), 026988111878332-1203. doi: 10.1177/0269881118783322

Real-world effectiveness of clozapine for intellectual disability: results from a mirror-image and a reverse-mirror-image study

2018

Journal Article

Prescriber and institutional barriers and facilitators of clozapine use: a systematic review

Verdoux, Hélène, Quiles, Clélia, Bachmann, Christian J. and Siskind, Dan (2018). Prescriber and institutional barriers and facilitators of clozapine use: a systematic review. Schizophrenia Research, 201, 10-19. doi: 10.1016/j.schres.2018.05.046

Prescriber and institutional barriers and facilitators of clozapine use: a systematic review

2018

Journal Article

Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review

Yolland, Caitlin O. B., Phillipou, Andrea, Castle, David J., Neill, Erica, Hughes, Matthew E., Galletly, Cherrie, Smith, Zoe M., Francis, Paul S., Dean, Olivia M., Sarris, Jerome, Siskind, Dan, Harris, Anthony W. F. and Rossell, Susan L. (2018). Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review. Nutritional Neuroscience, 23 (2), 1-10. doi: 10.1080/1028415X.2018.1478766

Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review

2018

Journal Article

Meta-analysis examining the epidemiology of clozapine-associated neutropenia

Myles, N., Myles, H., Xia, S., Large, M., Kisely, S., Galletly, C., Bird, R. and Siskind, D. (2018). Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta Psychiatrica Scandinavica, 138 (2), 101-109. doi: 10.1111/acps.12898

Meta-analysis examining the epidemiology of clozapine-associated neutropenia

2018

Journal Article

Augmentation strategies for clozapine refractory schizophrenia: a systematic review and meta-analysis

Siskind, Dan J., Lee, Michael, Ravindran, Arul, Zhang, Qichen, Ma, Evelyn, Motamarri, Balaji and Kisely, Steve (2018). Augmentation strategies for clozapine refractory schizophrenia: a systematic review and meta-analysis. Australian & New Zealand Journal of Psychiatry, 52 (8), 4867418772351-767. doi: 10.1177/0004867418772351

Augmentation strategies for clozapine refractory schizophrenia: a systematic review and meta-analysis

2018

Journal Article

The language we use - the effect of writing mental health care plans in the first person

Wyder, Marianne, Kisely, Steve, Meurk, Carla, Dietrich, Josie, Fawcett, Teresa, Siskind, Dan, Robinson, Gail and Crompton, David (2018). The language we use - the effect of writing mental health care plans in the first person. Australasian Psychiatry, 26 (5), 103985621877225-502. doi: 10.1177/1039856218772251

The language we use - the effect of writing mental health care plans in the first person

2018

Journal Article

A systematic review and meta-analysis of deep brain stimulation for depression

Kisely, Steve, Li, Amy, Warren, Nicola and Siskind, Dan (2018). A systematic review and meta-analysis of deep brain stimulation for depression. Depression and Anxiety, 35 (5), 468-480. doi: 10.1002/da.22746

A systematic review and meta-analysis of deep brain stimulation for depression

2018

Conference Publication

41.1 What do meta-analyses tell us about clozapine’s efficacy and effectiveness for treatment refractory schizophrenia?

Siskind, Dan, Kisely, Steve, Land, Rachel and McCartney, Lara (2018). 41.1 What do meta-analyses tell us about clozapine’s efficacy and effectiveness for treatment refractory schizophrenia?. Sixth Biennial SIRS Conference, Florence, Italy, 4-8 April 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby014.169

41.1 What do meta-analyses tell us about clozapine’s efficacy and effectiveness for treatment refractory schizophrenia?

Current funding

  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au